Detalles de la búsqueda
1.
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia.
Future Oncol;
20(14): 903-918, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353055
2.
Sunitinib for metastatic renal cell carcinoma: Real world data from the STAR-TOR registry and detailed literature review.
Urol Int;
2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310863
3.
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study.
Br J Nutr;
130(3): 495-502, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352765
4.
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction.
Urol Int;
106(10): 1041-1049, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144264
5.
Geriatric Assessments Can Predict Functional Outcome and Mortality after Urological Tumor Surgery.
Urol Int;
106(8): 848-857, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537771
6.
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial.
Int J Cancer;
148(4): 950-960, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738823
7.
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer;
148(7): 1685-1694, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070307
8.
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
Int J Cancer;
146(5): 1307-1315, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31498894
9.
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Future Oncol;
16(29): 2307-2328, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964728
10.
99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer.
Prostate;
78(1): 54-63, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29105797
11.
68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.
Eur J Nucl Med Mol Imaging;
45(11): 1862-1872, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725716
12.
The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape.
Future Oncol;
13(17): 1463-1471, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28523933
13.
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
BMC Cancer;
15: 455, 2015 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26040470
14.
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.
BMC Cancer;
15: 303, 2015 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925846
15.
Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany.
Urol Int;
95(2): 153-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25677365
16.
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.
BMC Cancer;
14: 214, 2014 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24650297
17.
Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.
Urol Int;
92(2): 174-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24334998
18.
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.
Lancet Oncol;
14(13): 1307-16, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24211163
19.
[Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?] / Geriatrisches Assessment Was sollte vor Therapiebeginn des mHSPC und des mCRPC gemacht und bedacht werden?
Aktuelle Urol;
55(2): 107-115, 2024 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-37748510
20.
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.
Urol Oncol;
2024 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403529